Canada markets open in 8 hours 3 minutes

Ondine Biomedical Inc. (OBI.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
8.250.00 (0.00%)
At close: 01:57PM BST
Currency in GBp

Valuation Measures4

Market Cap (intraday) 22.88M
Enterprise Value 21.47M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)23.41
Price/Book (mrq)19.00
Enterprise Value/Revenue 30.90
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 3-34.00%
S&P500 52-Week Change 324.96%
52 Week High 317.00
52 Week Low 30.00
50-Day Moving Average 37.05
200-Day Moving Average 38.90

Share Statistics

Avg Vol (3 month) 3311.06k
Avg Vol (10 day) 3105.76k
Shares Outstanding 5277.29M
Implied Shares Outstanding 6277.29M
Float 8133.53M
% Held by Insiders 150.04%
% Held by Institutions 17.52%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-874.19%

Management Effectiveness

Return on Assets (ttm)-82.98%
Return on Equity (ttm)-209.95%

Income Statement

Revenue (ttm)1.2M
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)106.10%
Gross Profit (ttm)N/A
EBITDA -14.59M
Net Income Avi to Common (ttm)-14.41M
Diluted EPS (ttm)-0.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.98M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)541k
Total Debt/Equity (mrq)25.95%
Current Ratio (mrq)1.36
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-13.65M
Levered Free Cash Flow (ttm)-8.44M